التفاصيل البيبلوغرافية
| العنوان: |
Anticoagulation practices in total pancreatectomy with autologous islet cell transplant patients: an international survey of clinical programs. |
| المؤلفون: |
Desai, Chirag S.1 (AUTHOR) chirag_desai@med.unc.edu, Szempruch, Kristen R.2 (AUTHOR), Vonderau, Jennifer S.1 (AUTHOR), Chetboun, Mikael3 (AUTHOR), Pattou, Francois3 (AUTHOR), Coates, Toby4 (AUTHOR), De Paep, Diedert Luc5 (AUTHOR), Hawthorne, Wayne J.6 (AUTHOR), Khan, Khalid M.7 (AUTHOR), Koning, Eelco J. P.8 (AUTHOR), Naziruddin, Bashoo9 (AUTHOR), Posselt, Andrew10 (AUTHOR), Schrope, Beth A.11 (AUTHOR), Wijkstrom, Martin12 (AUTHOR), Witkowski, Piotr13 (AUTHOR), Shapiro, A. M. James14 (AUTHOR) |
| المصدر: |
Transplant International. Mar2021, Vol. 34 Issue 3, p593-595. 3p. |
| مصطلحات موضوعية: |
*PANCREATECTOMY, *ISLANDS of Langerhans, *ANTICOAGULANTS, *PATIENT surveys, *TRANSPLANTATION of organs, tissues, etc. |
| مستخلص: |
Total pancreatectomy with autologous islet cell transplant (TPAIT) is a treatment option for patients suffering from chronic or recurrent acute pancreatitis by providing benefits of pain relief, enhancing quality of life, and preventing brittle type 3c diabetes [1]. In total, islet preparations were purified in 70 (57%) cases, partially purified in 23 (19%), or unpurified in 29 (24%) cases; three programs used routinely unpurified ( I n i = 30), and two routinely purified ( I n i = 4) islet preparations. [Extracted from the article] |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder